Biomerica, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BMRA Nasdaq 3840 www.biomerica.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biomerica, Inc.

Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development - May 28th, 2026 6:19 am
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 - Apr 29th, 2026 6:19 am
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway - Apr 16th, 2026 6:19 am
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - Apr 14th, 2026 6:19 am
Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Apr 13th, 2026 4:57 pm
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe - Mar 18th, 2026 6:19 am
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain - Mar 5th, 2026 6:19 am
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy - Feb 26th, 2026 6:19 am
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution - Feb 18th, 2026 6:19 am